Abstract
The slow aggregation assay is generally used to study the functionality of cell–cell adhesion complexes. Single cells are seeded on a semisolid agar substrate in a 96-well plate and the cells spontaneously aggregate. We used HEK FLAG-MOP cells that stably overexpress the mu opioid receptor and the mu-opioid-receptor-selective agonists DAMGO and morphine to study whether other factors than functionality of cell–cell adhesions complexes can contribute to changes in the pattern of slow aggregation on agar. HEK FLAG-MOP cells formed small compact aggregates. In the presence of DAMGO and morphine, larger and fewer aggregates were formed in comparison to the vehicle control. These aggregates were localized in the center of the agar surface, whereas in the vehicle control they were dispersed over the substrate. However, in suspension culture on a Gyrotory shaker, no stimulation of aggregation was observed by DAMGO and morphine, showing that opioids do not affect affinity. A dissociation experiment revealed that HEK FLAG-MOP aggregates formed in the absence or presence of opioids are resistant to de-adhesion. We demonstrated that the larger aggregates are neither the result of cell growth stimulation by DAMGO and morphine. Since manipulations of the substrate such as increasing the agar concentration or mixing agar with agarose induced the same changes in the pattern of slow aggregation as treatment with opioids, we suggest that cell–substrate adhesion may be involved in opioid-stimulated aggregation.
Similar content being viewed by others
References
Boterberg, T.; Bracke, M. E.; Bruyneel, E. A.; Mareel, M. M. Cell aggregation assays. In: Brooks S. A.; Schumacher U. (eds) Methods in molecular medicine, vol. 58: metastasis research protocols, vol. 2: cell behavior in vitro and in vivo. Humana, Totowa, pp 33–45; 2001.
Boterberg, T.; Vennekens, K. M.; Thienpont, M.; Mareel, M. M.; Bracke, M. E. Internalization of the E-cadherin/catenin complex and scattering of human mammary carcinoma cells MCF-7/AZ after treatment with conditioned medium from human skin squamous carcinoma cells COLO 16. Cell. Adhesion. Commun. 7: 299–310; 2000.
Bracke, M. E.; Charlier, C.; Bruyneel, E. A.; Labit, C.; Mareel, M. M.; Castronovo, V. Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Res. 54: 4607–4609; 1994.
Bracke, M. E.; Van Larebeke, N. A.; Vyncke, B. M.; Mareel, M. M. Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro. Br. J. Cancer 63: 867–872; 1991.
Canonici, A.; Steelant, W.; Rigot, V.; Khomitch-Baud, A.; Boutaghou-Cherid, H.; Bruyneel, E.; Van Roy, F.; Garrouste, F.; Pommier, G.; Andre, F. Insulin-like growth factor-I receptor, E-cadherin and av integrin form a dynamic complex under the control of a-catenin. Int. J. Cancer 122: 572–582; 2007. doi:10.1002/ijc.23164.
Gutstein, H. B.; Rubie, E. A.; Mansour, A.; Akil, H.; Woodgett, J. R. Opioid effects on mitogen-activated protein kinase signaling cascades. Anesthesiology 87: 1118–1126; 1997. doi:10.1097/00000542-199711000-00016.
Lahaye, M.; Rochas, C. Chemical structure and physico-chemical properties of agar. Hydrobiologia 221: 137–148; 1991. doi:10.1007/BF00028370.
Marie, N.; Lecoq, I.; Jauzac, P.; Allouche, S. Differential sorting of human ∂-opioid receptors after internalization by peptide and alkaloid agonists. J. Biol. Chem. 278: 22795–22804; 2003. doi:10.1074/jbc.M300084200.
McVey, M.; Ramsay, D.; Kellett, E.; Rees, S.; Wilson, S.; Pope, A. J.; Milligan, G. Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human ∂-opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. J. Biol. Chem. 276: 14092–14099; 2001.
Parenty, G.; Appelbe, S.; Milligan, G. CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-DOP receptor heterodimer. Biochem. J. 412: 245–256; 2008. doi:10.1042/BJ20071689.
Rong, H.; Boterberg, T.; Maubach, J.; Stove, C.; Depypere, H.; Van Slambrouck, S.; Serreyn, R.; De Keukeleire, D.; Mareel, M.; Bracke, M. 8-Prenylnaringenin, the phytoestrogen in hops and beer, upregulates the function of the E-cadherin/catenin complex in human mammary carcinoma cells. Eur. J. Cell Biol. 80: 580–585; 2001. doi:10.1078/0171-9335-00190.
Van Marck, V.; Stove, C.; Van Den Bossche, K.; Stove, V.; Paredes, J.; Vander Haeghen, Y.; Bracke, M. P-cadherin promotes cell–cell adhesion and counteracts invasion in human melanoma. Cancer Res. 65: 8774–8783; 2005. doi:10.1158/0008-5472.CAN-04-4414.
Vermeulen, S. J.; Nollet, F.; Teugels, E.; Vennekens, K. M.; Malfait, F.; Philippé, J.; Speleman, F.; Bracke, M. E.; Van Roy, F. M.; Mareel, M. M. The aE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells. Oncogene 18: 905–915; 1999. doi:10.1038/sj.onc.1202348.
Acknowledgements
Delphine Debruyne was an aspirant of the Fund for Scientific Research (FWO-Vlaanderen, Brussels, Belgium).
The authors thank G. Milligan for the HEK FLAG-MOP cells and G. De Bruyne for technical assistance. L. Thorrez is acknowledged for help with artwork and L. Vakaet for help with statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: J. Denry Sato
Rights and permissions
About this article
Cite this article
Debruyne, D., Mareel, M., Vanhoecke, B. et al. Cell aggregation on agar as an indicator for cell-matrix adhesion: effects of opioids. In Vitro Cell.Dev.Biol.-Animal 45, 473–482 (2009). https://doi.org/10.1007/s11626-009-9180-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-009-9180-y